BetterLife Pharma Inc.

Jul 27, 2020

BetterLife Pharma Provides Update on Proposed Acquisition of Altum and its Regulatory Guidance and Updated Clinical Development Plan

Jun 25, 2020

BetterLife Pharma Announces Consolidation of its Common Shares

Jun 11, 2020

BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum

Jun 09, 2020

BetterLife Pharma Announces OTC Trading Symbol Change to "BETRF" Effective June 9, 2020

Jun 04, 2020

BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum

May 25, 2020

BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum

May 19, 2020

BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board

May 15, 2020

BetterLife Pharma announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon

May 13, 2020

BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19

May 12, 2020

BetterLife Pharma Confirms Re-Pricing of Warrants

May 11, 2020

BetterLife Pharma Highlights Results from Recent Clinical Reports and Studies on use of Interferon and Announces Appointment of Dr. Mark Swaim and Engagement of IR Group

May 07, 2020

BetterLife Pharma Enters into a Licensing Agreement

Apr 07, 2020

BetterLife Pharma Provides Shareholder Update